Industry News (Lyme Disease)

In Lyme, No Rush for Vaccine

Published in Medical Letter on the CDC and FDA, June 28th, 1999

A Lyme Disease vaccine is getting the cold shoulder in the wooded enclave that gave the disease its name.

Experts say that if the LYMErix vaccine (SmithKline Beecham Pharmaceuticals) is going to be successful anywhere, Connecticut ought to be the place. Connecticut has the highest rate of the disease in the country - 105 cases per 100,000 people in 1998.

But five months after the vaccine came on the market, local doctors say people are not exactly lining up for injections.

"I've lived here for years and years, and I think you'll find that most people who've lived here for years aren't that excited about it," said Lyme First...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry